[Problems posed by the treatment of neurologic and neuropsychic manifestations of systemic lupus erythematosus].
D000328:Adult; D001264:Athetosis / Q000188:drug therapy / Q000209:etiology; D002819:Chorea / Q000188:drug therapy / Q000209:etiology; D003951:Diagnostic Errors; D004827:Epilepsy / Q000209:etiology; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000188:drug therapy; D001523:Mental Disorders / Q000188:drug therapy / Q000209:etiology*; D009404:Nephrotic Syndrome / Q000209:etiology; D009461:Neurologic Manifestations; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects*; D011605:Psychoses, Substance-Induced / Q000175:diagnosis*
D007166:Immunosuppressive Agents; D011241:Prednisone
Problèmes posés par le traitement des manifestations neurologiques et neuropsychiques du lupus érythémateux disséminé.